title: Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?
authors.affiliation: Department of Urology and Urologic Oncology, Hannover University Medical School, Hannover, Germany.
authors.forename: Sandra
authors.initials: S
authors.lastname: Waalkes
authors.forename: Frank
authors.initials: F
authors.lastname: Becker
authors.forename: Andres J
authors.initials: AJ
authors.lastname: Schrader
authors.forename: Martin
authors.initials: M
authors.lastname: Janssen
authors.forename: Gerd
authors.initials: G
authors.lastname: Wegener
authors.forename: Axel S
authors.initials: AS
authors.lastname: Merseburger
authors.forename: Mark
authors.initials: M
authors.lastname: Schrader
authors.forename: Rainer
authors.initials: R
authors.lastname: Hofmann
authors.forename: Michael
authors.initials: M
authors.lastname: Stöckle
authors.forename: Markus A
authors.initials: MA
authors.lastname: Kuczyk
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000145:classification* / Q000401:mortality / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000145:classification* / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D012189:Retrospective Studies